PRIMA US-Feasibility Study in Atrophic Dry AMD - Trial NCT03392324
Access comprehensive clinical trial information for NCT03392324 through Pure Global AI's free database. This phase not specified trial is sponsored by Pixium Vision SA and is currently Active, not recruiting. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 5 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Pixium Vision SA
Timeline & Enrollment
N/A
Apr 26, 2018
Dec 01, 2025
Primary Outcome
Near Visual Acuity
Summary
In this early feasibility trial the safety and performance of the new retinal prothesis PRIMA
 is tested in five subjects suffering from atrophic dry age related macular degeneration.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03392324
Device Trial